{"id":"https://openalex.org/W4387253104","doi":"https://doi.org/10.1161/atvb.43.suppl_1.484","title":"Abstract 484: Antidiabetic Agent, Canagliflozin, Is A Potent Vasodilator Of The Coronary Microvasculature","display_name":"Abstract 484: Antidiabetic Agent, Canagliflozin, Is A Potent Vasodilator Of The Coronary Microvasculature","publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4387253104","doi":"https://doi.org/10.1161/atvb.43.suppl_1.484"},"language":"en","primary_location":{"id":"doi:10.1161/atvb.43.suppl_1.484","doi":"https://doi.org/10.1161/atvb.43.suppl_1.484","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/atvb.43.suppl_1.484","pdf_url":null,"source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101691466","display_name":"Debolina Banerjee","orcid":"https://orcid.org/0000-0003-2341-310X","observed_orcids":["https://orcid.org/0000-0003-2341-310X"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]},{"id":"https://openalex.org/I2800446032","display_name":"Rhode Island Hospital","ror":"https://ror.org/01aw9fv09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800446032","https://openalex.org/I4210151747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debolina Banerjee","raw_affiliation_strings":["Brown Univ, Rhode Island Hosp, Providence, RI","Debolina Banerjee Brown Univ, Rhode Island Hosp, Providence, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brown Univ, Rhode Island Hosp, Providence, RI","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I2800446032"]},{"raw_affiliation_string":"Debolina Banerjee Brown Univ, Rhode Island Hosp, Providence, RI","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I2800446032"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hang Xing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]},{"id":"https://openalex.org/I2800446032","display_name":"Rhode Island Hospital","ror":"https://ror.org/01aw9fv09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800446032","https://openalex.org/I4210151747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hang Xing","raw_affiliation_strings":["Brown Univ, Rhode Island Hosp, Providence, RI","Hang Xing Brown Univ, Rhode Island Hosp, Providence, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brown Univ, Rhode Island Hosp, Providence, RI","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I2800446032"]},{"raw_affiliation_string":"Hang Xing Brown Univ, Rhode Island Hosp, Providence, RI","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I2800446032"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083654638","display_name":"Jun Feng","orcid":"https://orcid.org/0000-0003-4762-7532","observed_orcids":["https://orcid.org/0000-0003-4762-7532"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]},{"id":"https://openalex.org/I2800446032","display_name":"Rhode Island Hospital","ror":"https://ror.org/01aw9fv09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800446032","https://openalex.org/I4210151747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Feng","raw_affiliation_strings":["Brown Univ, Rhode Island Hosp, Providence, RI","Jun Feng Brown Univ, Rhode Island Hosp, Providence, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brown Univ, Rhode Island Hosp, Providence, RI","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I2800446032"]},{"raw_affiliation_string":"Jun Feng Brown Univ, Rhode Island Hosp, Providence, RI","institution_ids":["https://openalex.org/I2800446032"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012657061","display_name":"Frank William Sellke","orcid":"https://orcid.org/0000-0002-8886-801X","observed_orcids":["https://orcid.org/0000-0002-8886-801X"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]},{"id":"https://openalex.org/I2800446032","display_name":"Rhode Island Hospital","ror":"https://ror.org/01aw9fv09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800446032","https://openalex.org/I4210151747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Sellke","raw_affiliation_strings":["Brown Univ, Rhode Island Hosp, Providence, RI","Frank Sellke Brown Univ, Rhode Island Hosp, Providence, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brown Univ, Rhode Island Hosp, Providence, RI","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I2800446032"]},{"raw_affiliation_string":"Frank Sellke Brown Univ, Rhode Island Hosp, Providence, RI","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I2800446032"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5654000043869019,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5654000043869019,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.27730000019073486,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.026599999517202377,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/coronary-microcirculation","display_name":"coronary microcirculation","score":0.9800000190734863},{"id":"https://openalex.org/keywords/vasodilation","display_name":"vasodilation","score":0.9269999861717224},{"id":"https://openalex.org/keywords/endothelium-dependent-vasodilation","display_name":"endothelium-dependent vasodilation","score":0.925000011920929},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.8989999890327454},{"id":"https://openalex.org/keywords/myocardial-perfusion","display_name":"myocardial perfusion","score":0.7850000262260437},{"id":"https://openalex.org/keywords/endothelium-independent-relaxation","display_name":"endothelium-independent relaxation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/diabetic-microvascular-disease","display_name":"diabetic microangiopathy","score":0.593999981880188},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.765999972820282},{"id":"https://openalex.org/keywords/adenosine-5-diphosphate","display_name":"adenosine 5'-diphosphate","score":0.7889999747276306},{"id":"https://openalex.org/keywords/acetylcholine","display_name":"acetylcholine","score":0.9629999995231628}],"concepts":[{"id":"https://openalex.org/C120770815","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Vasodilation","level":2,"score":0.844325065612793},{"id":"https://openalex.org/C2779610285","wikidata":"https://www.wikidata.org/wiki/Q27108300","display_name":"Sodium nitroprusside","level":3,"score":0.7701848745346069},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.6810246706008911},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.5869256854057312},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5155661106109619},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5109812021255493},{"id":"https://openalex.org/C2779591629","wikidata":"https://www.wikidata.org/wiki/Q24745328","display_name":"Bradykinin","level":3,"score":0.4899806082248688},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.48878213763237},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48513635993003845},{"id":"https://openalex.org/C2909076160","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Coronary vasodilator","level":3,"score":0.44060957431793213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4363257884979248},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3379625380039215},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.206809401512146},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.12002909183502197},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/atvb.43.suppl_1.484","doi":"https://doi.org/10.1161/atvb.43.suppl_1.484","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/atvb.43.suppl_1.484","pdf_url":null,"source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388775997","https://openalex.org/W4388519616","https://openalex.org/W3114638071","https://openalex.org/W4389080889","https://openalex.org/W2205521320","https://openalex.org/W4390765157","https://openalex.org/W4413386305","https://openalex.org/W3207905766","https://openalex.org/W4404246142","https://openalex.org/W3006947875"],"abstract_inverted_index":{"Objective:":[0],"Sodium-glucose":[1],"cotransporter-2":[2],"(SGLT-2)":[3],"inhibitors":[4],"are":[5],"cardioprotective":[6],"even":[7],"in":[8,30,50,77,79,126,146,196,208,228,234,241],"the":[9,127,197,238],"absence":[10],"of":[11,37,90,118,129,162],"preexisting":[12],"diabetic":[13],"microvascular":[14,206],"disease.":[15],"Our":[16],"group":[17,199],"has":[18],"shown":[19],"SGLT-2":[20],"inhibitor,":[21],"canagliflozin,":[22],"increases":[23],"myocardial":[24,242],"perfusion":[25],"without":[26],"an":[27,160,194,209],"attendant":[28],"increase":[29,41,145,195,240],"angiogenesis.":[31],"We":[32],"hypothesize":[33],"canagliflozin":[34,59,246],"accentuates":[35],"vasodilation":[36,117,207],"coronary":[38],"microvasculature":[39],"to":[40,101,150,171,175,185],"perfusion.":[42],"Methods:":[43],"Coronary":[44],"resistance":[45],"arterioles":[46],"(174":[47],"\u00b1":[48],"60\u03bcm":[49],"diameter)":[51],"isolated":[52,120],"from":[53,121],"Sprague-Dawley":[54],"rats":[55,123],"either":[56],"receiving":[57],"daily":[58],"(15mg/kg,":[60],"oral":[61],"gavage)":[62],"for":[63,237],"four":[64],"weeks":[65],"(n":[66,72],"=":[67,73,153,180,201],"4)":[68,74],"or":[69,96],"no":[70],"treatment":[71,139],"were":[75,112],"studied":[76],"vitro":[78],"a":[80,143,187],"pressurized":[81],"(40mmHg),":[82],"no-flow":[83],"state":[84],"using":[85],"video":[86],"microscopy.":[87],"Following":[88],"preconstriction":[89],"microvessels":[91,119],"with":[92,142,158,245],"thromboxane":[93],"analog":[94],"U46619":[95],"endothelin-1,":[97],"concentration":[98],"response":[99,149,174,184],"curves":[100],"vasodilatory":[102,148,168,173,183],"adenosine":[103],"5\u2019-diphosphate":[104],"(ADP),":[105],"acetylcholine":[106],"(ACh),":[107],"and":[108,211,223,232],"sodium":[109],"nitroprusside":[110],"(SNP)":[111],"completed.":[113],"Additionally,":[114],"nitric-oxide-dependent":[115],"ADP-induced":[116],"treated":[122,198],"was":[124,140,177],"measured":[125],"presence":[128],"N":[130],"\u03c9":[131],"-Nitro-L-arginine":[132],"methyl":[133],"ester":[134],"(L-NAME)":[135],"10\u03bcM.":[136],"Results:":[137],"Canagliflozin":[138,204],"associated":[141],"significant":[144],"endothelium-dependent":[147,210],"ADP":[151],"(p":[152,179,200],"0.039)":[154],"(Figure":[155],"1).":[156],"Pretreatment":[157],"L-NAME,":[159],"inhibitor":[161],"nitric":[163,188],"oxide":[164,189],"synthase,":[165],"eliminated":[166],"this":[167],"response.":[169],"Compared":[170],"ADP,":[172],"ACh":[176],"muted":[178],"0.552).":[181],"Endothelium-independent":[182],"SNP,":[186],"donor,":[190],"strongly":[191],"trended":[192],"toward":[193],"0.099).":[202],"Conclusions:":[203],"improves":[205],"endothelium-independent":[212],"fashion":[213],"not":[214],"yet":[215],"described.":[216],"These":[217],"findings":[218],"implicate":[219],"both":[220],"vascular":[221],"endothelium":[222],"arteriolar":[224],"smooth":[225],"muscle":[226],"cells":[227],"altered":[229],"vasomotor":[230],"physiology":[231],"may,":[233],"part,":[235],"account":[236],"observed":[239],"blood":[243],"flow":[244],"treatment.":[247]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-10-03T00:00:00"}